I am actively involved in proteomics research within the Immunotechnology Department, with a primary focus on biomarker discovery for ovarian cancer. Utilizing advanced proteomic and phosphoproteomic techniques, my work aims to identify molecular signatures that could transform diagnostic and therapeutic strategies for this challenging disease. As a member of the proteomics group, I focus on deepening our understanding of cancer biology and its underlying mechanisms. Additionally, my research extends to cell-based assays, which serve as a critical tool in validating biomarkers and exploring cellular responses to potential treatments. By integrating these approaches, I aim to make meaningful contributions to cancer research and the development of strategies that could enhance patient outcomes.